Glycogen storage disease, type 8.
D000410:Alanine Transaminase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000032:analysis; D001786:Blood Glucose; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D005964:Glucosyltransferases / Q000097:blood / Q000378:metabolism*; D006008:Glycogen Storage Disease / Q000188:drug therapy / Q000473:pathology; D006529:Hepatomegaly / Q000201:enzymology; D006801:Humans; D007223:Infant; D007328:Insulin / Q000097:blood; D007773:Lactates / Q000097:blood; D007962:Leukocytes / Q000201:enzymology; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008107:Liver Diseases / Q000201:enzymology; D013577:Syndrome
D001786:Blood Glucose; D007328:Insulin; D007773:Lactates; D005964:Glucosyltransferases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D003981:Diazoxide